Dhurata Guillot
Acute Care · Watkinsville, GANPI 1841907722
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,616 of the $4,347 with a category attached, or 83.2%. It is spread thinly across 23 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,915, more than ten times the $107 reported in 2023. Among acute care clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $23.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$727
- Pacira Pharmaceuticals Incorporated$624
- Johnson & Johnson$519
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$410
- Takeda Pharmaceuticals U.S.A., Inc.$272
- Ardelyx, Inc.$256
- plus $2K from 17 others
What the payments were for
- Travel & lodging$54913%
- Food & beverage$3,61683%
- Education$1834%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $727 |
| Pacira Pharmaceuticals Incorporated | 5 | $624 |
| Johnson & Johnson | 15 | $519 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $410 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $272 |
| Ardelyx, Inc. | 9 | $256 |
| Ipsen Biopharmaceuticals, Inc | 6 | $208 |
| Sanofi | 9 | $203 |
| Lilly USA, LLC | 11 | $181 |
| Regeneron Healthcare Solutions, Inc. | 8 | $181 |
| QOL Medical, LLC | 6 | $152 |
| Aimmune Therapeutics, Inc. | 6 | $106 |
| Pfizer | 5 | $84 |
| Phathom Pharmaceuticals, Inc. | 6 | $76 |
| Bioventus LLC | 3 | $66 |
| Vivus LLC | 3 | $63 |
| Madrigal Pharmaceuticals | 3 | $61 |
| Boston Scientific | 1 | $40 |
| Exact Sciences | 2 | $33 |
| Novo Nordisk | 2 | $30 |
| Celltrion USA Inc. | 1 | $19 |
| Organon | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,347 in reported general payments places this provider in the 95th percentile of 679 acute care providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Watkinsville
- Darryl TurnerRinggold$21K
- Bryce CowgillCumming$16K
- Stacy CreelSavannah$15K
- Susan BeitzellAthens$13K
- Crystal KuhnCumming$12K
- Mark ClarkGainesville$10K
- Sarah WymanAtlanta$10K
- Jeffrey DillerAustell$10K
- Ayeshia PowellAtlanta$10K
- Mitzi WilliamsGainesville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.